Finnish congenital nephrotic syndrome: genes and variants
Finnish congenital nephrotic syndrome is linked to 2 analyzed proteins (NPHS1 and NPHS2). 71 DNA variants are known to cause it; 212 more are uncertain, and 1 of those already look disease-causing on computable evidence.
Last updated 2026-09-30. Research information, not medical advice.
Genes linked to Finnish congenital nephrotic syndrome
NPHS1: Nephrin
It forms a key structural and signaling component of the slit diaphragm between glomerular podocyte foot processes. Biallelic loss-of-function variants cause congenital nephrotic syndrome of the Finnish type with massive protein loss beginning early in life.
70 disease-causing and 211 uncertain variants in NPHS1 are linked to Finnish congenital nephrotic syndrome.
NPHS2: Podocin
It organizes nephrin-containing slit-diaphragm complexes in podocytes and helps maintain the glomerular filtration barrier. Biallelic pathogenic variants are a major cause of steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis.
1 disease-causing and 1 uncertain variants in NPHS2 are linked to Finnish congenital nephrotic syndrome.
Where Finnish congenital nephrotic syndrome variants cluster
- NPHS1 Ig-like C2-type 7 (positions 740–821): 8 of 70 disease-causing changes, 1.7× more than its size predicts.
- NPHS1 Ig-like C2-type 6 (positions 544–635): 8 of 70 disease-causing changes, 1.5× more than its size predicts.
Known disease-causing variants in Finnish congenital nephrotic syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NPHS1 P368L | 368 | Ig-like C2-type 4 | Disease-causing (★★) |
| NPHS1 P368S | 368 | Ig-like C2-type 4 | Disease-causing (★★) |
| NPHS1 V736A | 736 | Extracellular | Disease-causing (★★) |
| NPHS1 S366R | 366 | Ig-like C2-type 4 | Disease-causing (★★) |
| NPHS1 R711S | 711 | Extracellular | Disease-causing (★★) |
| NPHS1 R711H | 711 | Extracellular | Disease-causing (★★) |
| NPHS1 C623F | 623 | Ig-like C2-type 6 | Disease-causing (★★) |
| NPHS1 V709G | 709 | Extracellular | Disease-causing (★★) |
| NPHS2 R168H | 168 | Cytoplasmic | Disease-causing (★★) |
| NPHS1 P167L | 167 | Ig-like C2-type 2 | Disease-causing (★★) |
| NPHS1 R367C | 367 | Ig-like C2-type 4 | Disease-causing (★★) |
| NPHS1 L587R | 587 | Ig-like C2-type 6 | Disease-causing (★★) |
| NPHS1 G796R | 796 | Ig-like C2-type 7 | Disease-causing (★★) |
| NPHS1 G867D | 867 | Ig-like C2-type 8 | Disease-causing (★★) |
| NPHS1 L96V | 96 | Ig-like C2-type 1 | Disease-causing (★★) |
| NPHS1 G270C | 270 | Ig-like C2-type 3 | Disease-causing (★★) |
| NPHS1 S572N | 572 | Ig-like C2-type 6 | Disease-causing (★★) |
| NPHS1 G796E | 796 | Ig-like C2-type 7 | Disease-causing (★★) |
| NPHS1 R831C | 831 | Extracellular | Disease-causing (★★) |
| NPHS1 M1T | 1 | Disease-causing (★★) | |
| NPHS1 D105N | 105 | Ig-like C2-type 1 | Disease-causing (★★) |
| NPHS1 R802W | 802 | Ig-like C2-type 7 | Disease-causing (★★) |
| NPHS1 R888K | 888 | Ig-like C2-type 8 | Disease-causing (★★) |
| NPHS1 Y977C | 977 | Fibronectin type-III | Disease-causing (★★) |
| NPHS1 D310N | 310 | Ig-like C2-type 3 | Disease-causing (★★) |
| NPHS1 S350P | 350 | Ig-like C2-type 4 | Disease-causing (★★) |
| NPHS1 R407W | 407 | Ig-like C2-type 4 | Disease-causing (★★) |
| NPHS1 R460Q | 460 | Ig-like C2-type 5 | Disease-causing (★★) |
| NPHS1 P519S | 519 | Ig-like C2-type 5 | Disease-causing (★★) |
| NPHS1 R743C | 743 | Ig-like C2-type 7 | Disease-causing (★★) |
| NPHS1 A806D | 806 | Ig-like C2-type 7 | Disease-causing (★★) |
| NPHS1 S910P | 910 | Ig-like C2-type 8 | Disease-causing (★★) |
| NPHS1 V822M | 822 | Extracellular | Disease-causing (★★) |
| NPHS1 R711C | 711 | Extracellular | Disease-causing (★) |
| NPHS1 V736M | 736 | Extracellular | Disease-causing (★) |
| NPHS1 V834F | 834 | Extracellular | Disease-causing (★) |
| NPHS1 C160S | 160 | Ig-like C2-type 2 | Disease-causing (★) |
| NPHS1 L334P | 334 | Extracellular | Disease-causing (★) |
| NPHS1 A672T | 672 | Extracellular | Disease-causing (★) |
| NPHS1 P674L | 674 | Extracellular | Disease-causing (★) |
| NPHS1 C265R | 265 | Ig-like C2-type 3 | Disease-causing (★) |
| NPHS1 C465Y | 465 | Ig-like C2-type 5 | Disease-causing (★) |
| NPHS1 S569R | 569 | Ig-like C2-type 6 | Disease-causing (★) |
| NPHS1 P838T | 838 | Ig-like C2-type 8 | Disease-causing (★) |
| NPHS1 G967R | 967 | Fibronectin type-III | Disease-causing (★) |
| NPHS1 P243L | 243 | Ig-like C2-type 3 | Disease-causing (★) |
| NPHS1 C863R | 863 | Ig-like C2-type 8 | Disease-causing (★) |
| NPHS1 V957E | 957 | Fibronectin type-III | Disease-causing (★) |
| NPHS1 R976S | 976 | Fibronectin type-III | Disease-causing (★) |
| NPHS1 N673K | 673 | Extracellular | Disease-causing |
| NPHS1 A739V | 739 | Extracellular | Disease-causing |
| NPHS1 I742T | 742 | Ig-like C2-type 7 | Disease-causing |
| NPHS1 R802P | 802 | Ig-like C2-type 7 | Disease-causing |
| NPHS1 W64S | 64 | Ig-like C2-type 1 | Disease-causing |
| NPHS1 C528F | 528 | Ig-like C2-type 5 | Disease-causing |
| NPHS1 L643P | 643 | Extracellular | Disease-causing |
| NPHS1 W681C | 681 | Extracellular | Disease-causing |
| NPHS1 L832P | 832 | Extracellular | Disease-causing |
| NPHS1 I171N | 171 | Ig-like C2-type 2 | Disease-causing |
| NPHS1 I173N | 173 | Ig-like C2-type 2 | Disease-causing |
Showing 60 of 71.
Uncertain variants in Finnish congenital nephrotic syndrome that look disease-causing
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| NPHS1 S572G | 572 | Ig-like C2-type 6 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; S572N at the same position is pathogenic; seen in 4.1e-06 of gnomAD DNA copies; REVEL 0.666 |
Which prediction tools work for Finnish congenital nephrotic syndrome
How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 91 out of 100
- SIFT: 90 out of 100
- phyloP: 87 out of 100
- MetaLR: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Nephrotic syndrome is also caused by NPHS2 variants; they fall mostly in different places as the Finnish congenital nephrotic syndrome variants (30 disease-causing).
- Steroid-resistant nephrotic syndrome is also caused by NPHS2 variants; they fall mostly in different places as the Finnish congenital nephrotic syndrome variants (8 disease-causing).
- Idiopathic nephrotic syndrome is also caused by NPHS2 variants; they fall mostly in different places as the Finnish congenital nephrotic syndrome variants (5 disease-causing).
Diseases related to Finnish congenital nephrotic syndrome
- Nephrotic syndrome, also linked to NPHS1 and NPHS2
- Focal segmental glomerulosclerosis, also linked to NPHS1 and NPHS2
- Steroid-resistant nephrotic syndrome, also linked to NPHS2
- Idiopathic nephrotic syndrome, also linked to NPHS2
- Kidney disorder, also linked to NPHS1
Frequently asked questions
Which genes are linked to Finnish congenital nephrotic syndrome?
In CATVariant, Finnish congenital nephrotic syndrome is linked to 2 analyzed proteins: NPHS1 (Nephrin) and NPHS2 (Podocin).
How many genetic variants are linked to Finnish congenital nephrotic syndrome?
287 variants: 71 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 212 are of uncertain significance or have conflicting reports.
Which uncertain variants in Finnish congenital nephrotic syndrome look disease-causing?
1 uncertain variants reach the likely-pathogenic range of the ACMG/AMP points scale on computable evidence, for example NPHS1 S572G. These are leads for expert review, not diagnoses.
Which variant effect predictor works best for Finnish congenital nephrotic syndrome?
Among tools not trained on clinical labels, CADD separates this disease's known disease-causing variants from harmless ones best (AUROC 0.91, based on 47 disease-causing and 41 harmless variants).
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center